Ardent Health, Inc. insider trading

ARDTNYSE

$10.88+0.20 (+1.87%)as of Oct 7, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 7, 2025 to Oct 7, 2026. Price (-25.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

MBMartin BonickPresident and CEO1.0195%of company
SCStephen C. PetrovichEVP, GC and Secretary0.8128%of company
ALAlfred LumsdaineChief Financial Officer0.231%of company
DCDave CaspersCEO and President0.124%of company
DRDavid Raynor ByersSVP & Chief Accounting Officer0.0921%of company
WMWilliam M. GoodyearDirector0.0818%of company
PCPeter C. B. BynoeDirector0.0818%of company
EHEllen HavdalaDirector0.0818%of company
RTRobert Thomas WebbDirector0.0555%of company
ECEthan CherninPresident of Health Services0.0485%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
ARDT	Robert DeMichieiDirector	Open market purchase$98.3K	+46.3%	$8.73	$98.3K	Jun 5, 2026	Jun 8, 2026
ARDT	Alfred LumsdaineChief Financial Officer	Open market purchase$88.1K	+3.1%	$8.81	$88.1K	Jun 5, 2026	Jun 8, 2026

End of history · 2 transactions